The Cancer Couch Foundation

My name is Dylan Van Fleet, and my mom Lisa Nicholson is a metastatic breast cancer fighter.  She was first diagnosed with breast cancer in 2015, when I was in 7th grade, which then metasticized in 2017.  She has been a true fighter ever since.  With everything she and countless others have to go through- numerous chemotherapy treatments,  multiple radiation sessions, pain, nausea, and so much more, I want to help raise awareness as much as I can, and in my own way.  Fighting  cancer takes a huge amount of effort and strength.  In honor of this strength,  I am hiking the Appalachian Trail this spring, a 2200 mile trail that runs from Georgia to Maine, to raise awareness and funds for research to combat metastatic breast cancer (MBC).

The donations I collect will go to the Cancer Couch Foundation, a non-profit that funds metastatic breast cancer research.  All funding is matched so not only do 100% of donations go straight to the cause - your money is doubled - making twice the impact.  Please join me in making a difference!  Thanks in advance for your contribution to this cause that means so much to me and so many others who have to fight this terrible disease.

More information about Cancer Couch Foundation Inc (The Cancer Couch Foundation): The Cancer Couch Foundation (TCCF) is a 501c3 non-profit corporation founded by Rebecca Timlin-Scalera, PhD, in 2016 to raise money exclusively for research on metastatic breast cancer (mbc). After her diagnosis in 2015, Rebecca quickly became aware of the dire need for more funding for this stage of the disease. 1 in 8 women will be diagnosed with invasive breast cancer, and 30% of those with early stage breast cancer (Stages 1-3) will eventually be re-diagnosed with mbc (Stage 4). While there are thankfully more treatments becoming available for mbc, there is still no cure, and the average prognosis remains at 2-3 years. Rebecca passed away on December 14, 2019, but her passion to end this disease lives on in The Cancer Couch Foundation.  TCCF funds two cutting edge labs led by Dr. Nikhil Wagle of Dana Farber, and Dr. Sarat Chandarlapaty at Memorial Sloan Kettering Cancer Center.